Search by Drug Name or NDC
NDC 00409-0801-01 Nipent 2 mg/mL Details
Nipent 2 mg/mL
Nipent is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is PENTOSTATIN.
MedlinePlus Drug Summary
Pentostatin is used to treat hairy cell leukemia (cancer of a certain type of white blood cell). Pentostatin is a type of antibiotic that is only used in cancer chemotherapy. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 00409-0801-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Pentostatin Injection
Product Information
| NDC | 00409-0801 |
|---|---|
| Product ID | 0409-0801_d0a07732-fd08-4f3e-bbc8-cb039f6b9026 |
| Associated GPIs | 21700045002120 |
| GCN Sequence Number | 016510 |
| GCN Sequence Number Description | pentostatin VIAL 10 MG INTRAVEN |
| HIC3 | V1B |
| HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
| GCN | 19901 |
| HICL Sequence Number | 006301 |
| HICL Sequence Number Description | PENTOSTATIN |
| Brand/Generic | Brand |
| Proprietary Name | Nipent |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PENTOSTATIN |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/mL |
| Substance Name | PENTOSTATIN |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020122 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-0801-01 (00409080101)
| NDC Package Code | 0409-0801-01 |
|---|---|
| Billing NDC | 00409080101 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) / 5 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2007-08-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |